<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>Moxi by Emulate | Ben Swenor | Activity</title>
	<link>https://dev.moxi.clayglobaldev.com/members/bswenor/activity/</link>
	<atom:link href="https://dev.moxi.clayglobaldev.com/members/bswenor/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Ben Swenor.</description>
	<lastBuildDate>Mon, 08 May 2023 09:36:04 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=2.3.3</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">8158c041ed9267ae6289237ab5749609</guid>
				<title>Ben Swenor replied to a discussion in the forum Reproductive</title>
				<link>https://dev.moxi.clayglobaldev.com/forums/topic/a-breakthrough-in-bacterial-vaginosis-treatment-for-womens-health/#post-852</link>
				<pubDate>Thu, 12 Jan 2023 17:22:18 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://dev.moxi.clayglobaldev.com/forums/discussion/a-breakthrough-in-bacterial-vaginosis-treatment-for-womens-health/#post-852"><span class="bb-reply-lable">Reply to</span> Ask Me Anything: I created a Vagina-on-a-Chip</a></p> <div class="bb-content-inr-wrap"><p>Hi Gautam,</p>
<p>Did you grow any chips in low oxygen environment (hypoxic incubator) or was just based upon the COMSOL model sufficient to maintain low enough O2 levels on Chip?</p>
<p>Did you do any work looking at adding post-biotics on chip to see how that could be used to aid in a healthier vaginal microbiome?</p>
<p>Thanks!</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">017d1a2bcedd2143d4d36871197679b1</guid>
				<title>Ben Swenor started a new discussion in the forum *Perspectives</title>
				<link>https://dev.moxi.clayglobaldev.com/forums/topic/organ-chips-for-transforming-personalized-medicine/</link>
				<pubDate>Wed, 30 Nov 2022 16:22:18 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://dev.moxi.clayglobaldev.com/forums/discussion/organ-chips-for-transforming-personalized-medicine/"> Organ-Chips for Transforming Personalized Medicine</a></p> <div class="bb-content-inr-wrap"><p>&lt;p style=&#8221;font-weight: 400;&#8221;&gt;I read that the precision medicine market is expected to reach $88 billion this year, driven in large part by the advancing tide of technological innovation. No doubt, in my opinion, MPS systems and specifically , Organ-Chip technology should be counted among this tide.&lt;/p&gt;<br />
&lt;p style=&#8221;font-weight: 400;&#8221;&gt;&lt;/p&gt;<br />
&lt;p&hellip;<span class="activity-read-more" id="activity-read-more-833"><a href="https://dev.moxi.clayglobaldev.com/forums/topic/organ-chips-for-transforming-personalized-medicine/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0cfb295ab3529613ca4cb49be534cad1</guid>
				<title>Ben Swenor replied to a discussion in the forum *Perspectives</title>
				<link>https://dev.moxi.clayglobaldev.com/forums/topic/how-do-you-validate-3d-in-vitro-culture-systems/#post-776</link>
				<pubDate>Mon, 24 Oct 2022 17:41:26 -0400</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://dev.moxi.clayglobaldev.com/forums/discussion/how-do-you-validate-3d-in-vitro-culture-systems/#post-776"><span class="bb-reply-lable">Reply to</span> How do you validate 3D in vitro culture systems? </a></p> <div class="bb-content-inr-wrap"><p>@Stephen &#8211; My perspective would be that the model would then be caveated for that particular marker. My main reasoning being that it isn&#8217;t necessarily a flaw of the model, but a donor variability. It certainly could be a deficit of the model, but that is a large component of why having multiple donors for a given model is so critical. It allows us&hellip;<span class="activity-read-more" id="activity-read-more-772"><a href="https://dev.moxi.clayglobaldev.com/forums/topic/how-do-you-validate-3d-in-vitro-culture-systems/#post-776" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>
		